FGFR1 underlies obesity-associated progression of estrogen receptor–positive breast cancer after estrogen deprivation

Obesity increases breast cancer mortality by promoting resistance to therapy. Here, we identified regulatory pathways in estrogen receptor–positive (ER-positive) tumors that were shared between patients with obesity and those with resistance to neoadjuvant aromatase inhibition. Among these was fibro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Wellberg, Elizabeth A., Kabos, Peter, Gillen, Austin E., Jacobsen, Britta M., Brechbuhl, Heather M., Johnson, Stevi J., Rudolph, Michael C., Edgerton, Susan M., Thor, Ann D., Anderson, Steven M., Elias, Anthony, Zhou, Xi Kathy, Iyengar, Neil M., Morrow, Monica, Falcone, Domenick J., El-Hely, Omar, Dannenberg, Andrew J., Sartorius, Carol A., MacLean, Paul S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6124402/
https://ncbi.nlm.nih.gov/pubmed/30046001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.120594
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados